Alinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in...

FDA Device Recall #Z-2276-2021 — Class II — July 12, 2021

Recall Summary

Recall Number Z-2276-2021
Classification Class II — Moderate risk
Date Initiated July 12, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Laboratories, Inc
Location Irving, TX
Product Type Devices
Quantity 260 systems

Product Description

Alinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donor screening, plasma and plasmapheresis screening, and organ donor centers, hospitals, and reference laboratories.

Reason for Recall

A design defect (hardware and software) allows liquid waste pressure to build up and potentially spray users/operators.

Distribution Pattern

Worldwide distribution. US nationwide, Australia, Bahrain, Belgium, Brazil, China, Colombia, Croatia, Egypt, Germany, Greece, Hong Kong, Hungary, Iran, Ireland, Israel, Italy, Jordan, Kuwait, Mexico, Netherlands, Pakistan, Poland, Portugal, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Tanzania, United Arab Emirates, United Kingdom, Ukraine and Zimbabwe.

Lot / Code Information

Model Number: LN 06P16-01 Serial numbers AS1001 through AS1330

Other Recalls from Abbott Laboratories, Inc

Recall # Classification Product Date
Z-0749-2022 Class II Alinity s System software version2.8.0, REF LN ... Feb 3, 2022
Z-1671-2020 Class II ARCHITECT C System Mixer - Product Usage: The A... May 1, 2019
Z-0971-2019 Class II ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-... Jan 2, 2019
Z-2755-2019 Class II APS Accelerator modular systems, 208-230 V-, 50... Sep 7, 2018
Z-1296-2019 Class II Abbott ARCHITECT cSystems ICT Module, REF 09D28... Aug 28, 2018

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.